Cargando…

In Silico Design of New Dual Inhibitors of SARS-CoV-2 M(PRO) through Ligand- and Structure-Based Methods

The viral main protease is one of the most attractive targets among all key enzymes involved in the life cycle of SARS-CoV-2. Considering its mechanism of action, both the catalytic and dimerization regions could represent crucial sites for modulating its activity. Dual-binding the SARS-CoV-2 main p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bono, Alessia, Lauria, Antonino, La Monica, Gabriele, Alamia, Federica, Mingoia, Francesco, Martorana, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179319/ https://www.ncbi.nlm.nih.gov/pubmed/37176082 http://dx.doi.org/10.3390/ijms24098377

Ejemplares similares

In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents
por: Bono, Alessia, et al.
Publicado: (2023)

Design and Synthesis of Novel Thieno[3,2-c]quinoline Compounds with Antiproliferative Activity on RET-Dependent Medullary Thyroid Cancer Cells
por: La Monica, Gabriele, et al.
Publicado: (2023)

Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure–Activity Relationship Insights and Evolution Perspectives
por: La Monica, Gabriele, et al.
Publicado: (2022)

Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors
por: Monica, Gabriele La, et al.
Publicado: (2021)

Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel
por: Martorana, Annamaria, et al.
Publicado: (2022)

In Silico Identification of Small Molecules as New Cdc25 Inhibitors through the Correlation between Chemosensitivity and Protein Expression Pattern
por: Lauria, Antonino, et al.
Publicado: (2021)

In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
por: Martorana, Annamaria, et al.
Publicado: (2020)

Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways
por: Martorana, Annamaria, et al.
Publicado: (2020)

Antiproliferative Properties and G-Quadruplex-Binding of Symmetrical Naphtho[1,2-b:8,7-b’]dithiophene Derivatives
por: Lauria, Antonino, et al.
Publicado: (2021)

Synthesis, biological evaluation, and in silico studies of novel chalcone- and pyrazoline-based 1,3,5-triazines as potential anticancer agents
por: Moreno, Leydi M., et al.
Publicado: (2020)

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta
por: Longo, Valeria, et al.
Publicado: (2020)

In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro))
por: Falade, Victoria Adeola, et al.
Publicado: (2021)

Non-covalent SARS-CoV-2 M(pro) inhibitors developed from in silico screen hits
por: Rossetti, Giacomo G., et al.
Publicado: (2022)

Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 M(Pro) and PL(Pro)
por: Kattula, Bhavita, et al.
Publicado: (2023)

Discovery of SARS-CoV-2 M(pro) peptide inhibitors from modelling substrate and ligand binding
por: Chan, H. T. Henry, et al.
Publicado: (2021)

Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization
por: Di Sarno, Veronica, et al.
Publicado: (2021)

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M(pro)) Inhibitors
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2021)

In vitro and in silico studies of SARS-CoV-2 main protease M(pro) inhibitors isolated from Helichrysum bracteatum
por: Wahab, Gehad Abdel, et al.
Publicado: (2022)

Synthesis and in Silico Investigation of Organoselenium-Clubbed Schiff Bases as Potential M(pro) Inhibitors for the SARS-CoV-2 Replication
por: Shaaban, Saad, et al.
Publicado: (2023)

In silico studies of anti-oxidative and hot temperament-based phytochemicals as natural inhibitors of SARS-CoV-2 M(pro)
por: Naderi Beni, Ramin, et al.
Publicado: (2023)

Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 M(pro) inhibitors
por: Mohamed, Nada M., et al.
Publicado: (2021)

Jagged Ligands Enhance the Pro-Angiogenic Activity of Multiple Myeloma Cells
por: Palano, Maria Teresa, et al.
Publicado: (2020)

Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors
por: Oliveira, Catarina, et al.
Publicado: (2018)

An In-silico Screening Strategy to the Prediction of New Inhibitors of COVID-19 M(pro) Protein
por: Abbasi, Maryam, et al.
Publicado: (2021)

In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D
por: Protić, Sara, et al.
Publicado: (2023)

Discovery of PL(pro) and M(pro) Inhibitors for SARS-CoV-2
por: Puhl, Ana C., et al.
Publicado: (2023)

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Identification of a Novel Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase: In Vitro and In Silico Studies
por: de Almeida, Raquel B. M., et al.
Publicado: (2023)

Assessment of activity of chalcone compounds as inhibitors of 3-chymotrypsin like protease (3CL(Pro)) of SARS-CoV-2: in silico study
por: Mathpal, Shalini, et al.
Publicado: (2022)

In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
por: Maulana, Saipul, et al.
Publicado: (2023)

In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CL(pro)) and SARS-CoV-2 (M(pro))
por: Vergoten, Gérard, et al.
Publicado: (2021)

Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors
por: Horchani, Mabrouk, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 3CL(Pro) Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions
por: Wang, Yaxin, et al.
Publicado: (2022)

In silico approach for identification of natural compounds as potential COVID 19 main protease (M(pro)) inhibitors
por: Chaturvedi, Monika, et al.
Publicado: (2021)

Pro-Resolving Ligands Orchestrate Phagocytosis
por: Decker, Christa, et al.
Publicado: (2021)

Neoechinulin A as a Promising SARS-CoV-2 M(pro) Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors
por: Alhadrami, Hani A., et al.
Publicado: (2022)

In silico analysis of selected alkaloids against main protease (M(pro)) of SARS-CoV-2
por: Garg, Saksham, et al.
Publicado: (2020)

In‐silico analysis of the strigolactone ligand‐receptor system
por: Bürger, Marco, et al.
Publicado: (2020)

In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (M(pro)) and spike (S) receptor
por: Dermawan, Doni, et al.
Publicado: (2021)

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ejilu3jcmbrejhc30ak1ojjb1d